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In Summer, No Slackers
Alumna Pumps Up  
Her Education
Spring/Summer 2009
“Perinatal Outcomes in Nutritionally  Monitored Obese Pregnant 
Women,” The Journal of the National Medical Association, June 2009. 
Online at http://www.nmanet.org/index.php/Publications_Sub/jnma
Researchers examine quality of life after 
cancer 
Cancer treatment has become so advanced in recent 
years that a diagnosis no longer spells certain death as 
it once did. In fact, many cancer patients, after under-
going successful treatment, readily return to their jobs 
and their lives, apparently restored to the good health 
and quality of life they enjoyed before they became 
ill. But not every cancer patient can look forward to 
such a rosy outcome. Have we become unrealistic in 
expectations of cancer treatment?
A recent study led by Frank Baker, Ph.D., School 
of Health Sciences and Practice, examined quality of 
life issues for cancer patients. The team obtained data 
from 16,850 individuals aged 65 years and older who 
were enrolled in Medicare managed care plans and 
who had completed a quality-of-life questionnaire in 
1998 and again in 2000. For those previously diagnosed 
with cancer, there was no evidence that their quality of 
life returned to normal levels (i.e, before onset of the 
disease) after two years. Quality of life declined  
for all participants over the two years studied as 
age increased. Those who previously had cancer had 
poorer quality of life than those without cancer at 
both times.  However, the rate that quality of life 
worsened was the same for both groups. The change 
in quality of life was also greater for physical health as 
compared to mental health.
The researchers advise that physicians treating elderly 
individuals with cancer should be aware that both 
Moderating calorie intake during pregnancy 
won’t harm the fetus
Although obesity in pregnancy continues to be 
associated with a host of health problems, many 
clinicians have been reluctant to place non-diabetic, 
obese pregnant women on a monitored, calorie-
appropriate nutritional regimen for fear of limiting 
fetal growth or even precipitating low birthweight 
or starvation ketosis. 
A new study led by Yvonne S. Thornton,  
M.D., M.P.H., clinical professor of obstetrics  
and gynecology, reports that obese women can  
be placed on a healthy, well-balanced, monitored  
nutritional program during pregnancy without 
adversely affecting the fetus.
A total of 257 patients were enrolled in the study 
in which patients were given either conventional 
prenatal dietary management or were prescribed 
a balanced nutritional regimen and were asked to 
record in a diary all of the foods eaten during each 
day. The results showed that pregnant women who 
adhered to the balanced regimen and recorded 
their food intake were less likely to develop  
gestational hypertension, had less weight gain  
during pregnancy, and were quicker to return to 
their prenatal weight within six weeks of delivery. 
Patients gaining 15 pounds or more during their 
pregnancy showed statistically significant differences 
between the groups for eight variables. 
The researchers concluded that obstetricians 
can safely place their obese patients on a healthy, 
monitored nutrition program during pregnancy 
without fear of compromising the health of either 
the mother or the baby.
(continued on page 32)
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For the first time, Chironian’s personality profile features not one but two high-powered individuals who contribute tirelessly to the 
mission of the College: Leonard J. Newman, M.D., ’70, professor and chairman of the Department of Pediatrics, at right, and Michael H. 
Gewitz, M.D., professor and department vice chairman and executive director and physician in chief at Maria Fareri Children’s Hospital/
Westchester Medical Center. Both are pediatricians with busy practices (although none of the giggling preschoolers who posed for our 
cover shot in the lobby of the Children’s Hospital are patients of the good doctors). Colleagues say they make a remarkable team, working 
together to manage the academic and clinical needs of the Department of Pediatrics, both at the College and at the Children’s Hospital. 
Special thanks to Wendy Masserman, director of For Kids Only in Briarcliff Manor, N.Y., her staff and those irrepressible kids. 
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Collaborators, Educators, Administrators— 
and They Even Do Translational Research
Together and individually, Jan Geliebter, Ph.D., and Raj Tiwari, Ph.D.,  
are investigating malignancies of the breast and prostate,  
and training a new generation of scientists—all without missing a beat.
                                                                          
By Dan Hurley
Left: The research teams of Raj Tiwari, Ph.D., seated center, and Jan Geliebter, 
Ph.D., standing center and at right, each have a distinct focus, but their paths 
cross often in the course of their collaborations. Surrounding the two lead 
investigators are, clockwise from left: Ismael Reyes, Ph.D., post-doctoral 
fellow; Scott Nowicki, M.D./Ph.D. student; Josh Bedwell, M.D., otolaryngology 
resident; Robert Suriano, Ph.D. ’07, post-doctoral fellow; visiting exchange 
student Parthajit Mukharjee;  Andrea George, Ph.D. candidate; Arulkumaran 
Shanmugam, Ph.D., post-doctoral fellow; and Shilpi Rajoria, Ph.D. candidate.
T he wiry, animated Jan Geliebter, Ph.D., stands, gestures at his jottings on a white board, and begins talking a mile a minute while his colleague, the considerably more relaxed Raj Tiwari, 
Ph.D., eases back in his chair, his hands clasped behind his head. You’d 
never know it, but they are discussing their educational backgrounds.
“I’m from Brooklyn; you got a problem with that, we’ll take it out-
side,” jokes Dr. Geliebter. “I got my Ph.D. from Calcutta University,” 
Dr. Tiwari puts in. “I speak too quickly, he speaks too slowly,” quips  
Dr. Geliebter.  “I have to compensate.”
Different as they are, the two men have formed a close partnership 
on their research in preventing, diagnosing and treating cancers,  
particularly of the thyroid, prostate and breast. They also share a 
passion for teaching and administration, and with a cadre of students, 
fellows, post-docs and residents all playing a role in their sizable body 
of research, they like to say they are training the next generation.
Both are professors in the Department of Microbiology and  
Immunology, and each has administrative responsibilities—Geliebter 
as course director and Tiwari as graduate program director. Both 
men have appointments in the Department of Otolaryngology, 
where Dr. Geliebter is also the resident research coordinator.
“They work so well together,” says Ira Schwartz, Ph.D., professor  
and chairman of the Department of Microbiology and Immunology.  
“They are a perfect complement. And at a personal level, they’re 
very close friends. It’s a very prolific partnership that they’ve  
developed.”
Some of their most productive work has been investigating a  
potent cancer-preventing compound found in all cruciferous  
vegetables called 3,3’-Diindolymethane, or DIM, which Dr. Tiwari  
has studied since 1994. A 2005 paper they co-authored with a  
team of researchers and clinicians, some of whom practice at  
The New York Eye and Ear Infirmary (NYEEI), a College affiliate 
in Manhattan, showed that DIM is a potent anti-proliferative agent 
against thyroid cancer, and inhibits the growth of primary goiter  
cells by 70 percent. 
Dr. Tiwari is principal investigator leading a team of clinicians and 
basic scientists on an NIH-funded R01 grant to study the basic 
biology of DIM, as well as its clinical efficacy in thyroid proliferative 
diseases. In addition, he and Dr. Geliebter are working with princi-
pal investigator Stimson Schantz, M.D., professor of otolaryngology, 
who is recruiting patients for a clinical trial of DIM. The study will 
examine patients with goiter who will undergo surgery, to see if DIM 
improves their outcomes versus a placebo. Drs. Tiwari and Schantz 
have a long and successful history of collaborating since their days 
together at Memorial Sloan-Kettering Cancer Center. Collaborators, Educators, Administrators— 
and They Even Do Translational Research
                                                                          
By Dan Hurley
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“What is found in cancer cells but 
not in normal cells can be used 
as a biomarker for diagnosis or 
prognosis of cancer or as a target 
for therapeutic intervention.”
– Jan Geliebter, Ph.D.
In Dr. Geliebter’s lab, the team uses microarray technology to identify 
molecular differences between normal and cancerous thyroid tissue for 
the discovery of molecular biomarkers and therapeutic targets such as 
ALOX-5. Down at New York Eye and Ear, otolaryngology residents are 
studying genes identified as potential molecular biomarkers. A skilled 
team of pathologists and technicians provide clinical samples for the  
research. All are overseen by Dr. Schantz, who provides necessary  
clinical input (see sidebar on page 6).
DIM is just one of many compounds being investigated by the research-
ers. The College now owns the patent on a novel anti-cancer agent 
called C 1748, developed by Dr. Tiwari in collaboration with researchers 
from as far away as Gdansk, Poland. Building on compounds developed 
in Poland in the 1970s, Dr. Tiwari sought one that would exhibit more 
potent effects on tumors with less systemic toxicity. The most active  
and least toxic proved to be the substance C-1748, also known as 
nitroacridine. To pave the way for a human trial targeting prostate  
cancer, Dr. Tiwari’s group published a 2006 paper in Life Sciences  
showing that, in sharp contrast to most chemotherapeutic agents, 
nitroacridine produced only minimal and transient side effects.
New treatments on the horizon
“There is currently no approved chemotherapy for prostate cancer,”  
Dr. Tiwari says. “We have finished our toxicology and pre-clinical work, 
and are looking for partners to initiate a clinical trial.”
On the basic biology front, Dr. Tiwari has recently discovered progenitor 
stem cells that promote the vascularization of breast cancer cells. As 
senior author of a paper published last August in the journal Cancer  
Research, he and post-doctoral fellow Robert Suriano, Ph.D. ’07, 
Nothing lost in translation
At its root, their plan is to conduct research that translates directly 
into improved patient care, whether through prevention, diagnosis or 
treatment. The two researchers view their thyroid investigations as 
true translational research, a collaboration among clinicians who fully 
understand the disease and the concerns of the patient, and the basic 
scientists who carry out the bench studies to address the issues. As 
Dr. Tiwari points out, “If research cannot be translated, it may not have 
value in a medical setting.” 
Both Geliebter’s and Tiwari’s groups are taking an integrated genomics 
approach to thyroid cancer, “where we are looking at the sum total 
of all the molecules in normal and cancerous thyroid cells and asking 
what is different between them,” explains Dr. Geliebter. “What is found 
in cancer cells but not in normal cells can be used as a biomarker 
for diagnosis or prognosis of cancer or as a target for therapeutic 
intervention.”
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described bone marrow-derived endothelial progenitor cells that are 
mobilized by the hormone 17ß-estradiol. 
“We are very excited about the findings,” he says. “We are using adult 
stem cells that are important in making new blood vessels, and targeting 
those new blood vessels for therapy in both breast and thyroid cancer.”
Dr. Tiwari is also hard at work on an experimental vaccine that would 
boost the immune system’s ability to recognize and destroy cancer cells.
“We wondered why the immune system doesn’t always recognize a  
cancer as foreign,” he says. “We felt it becomes too tolerant. So we 
looked for a way to boost the immune system.” His lab is finding  
synthetic peptides that mimic the cancer, different enough from the 
standard tumor cells to stimulate an immune reaction, but similar enough 
to result in the immune system also attacking the cancer. This is called 
cross-reactivity between the peptide mimic and the native antigen.  
 “The animal studies are very encouraging. We are collaborating with 
Abraham Mittelman [M.D., clinical associate professor of medicine,] for 
patient-based clinical research,” says Dr. Tiwari, who co-authored a review 
article with Dr. Geliebter earlier this year on the fast-growing field of 
cancer immunotherapy. He adds, “We have licensed this to a company 
that is funding the vaccine work.”
Dr. Geliebter’s laboratory studies prostate and thyroid cancer on the 
molecular level. In particular, his group is interested in the etiology of the 
diseases, as well as molecular biomarkers for the diagnosis and prognosis 
of these cancers. For example, his laboratory is studying the effects of 
diet, aging, environmental factors and oxidative stress on the initiation 
and promotion of prostate cancer. Brother and sister post-docs Ismael 
Reyes, Ph.D., and Niradiz Reyes-Ramos, Ph.D. ’03, have found that a high 
fat diet and the aging process each independently increase oxidative 
stress in the prostate, resulting in genetic damage and inflammation. 
Together the effects are synergistic, multiplying the chances for cancer. 
“The prostate in a young rat on a high fat diet has the same level of 
oxidative stress levels as a prostate from a much older rat on a low 
fat diet. Think of the high fat diet we eat in the U.S., and there is no 
wonder that prostate cancer rates have skyrocketed,” Dr. Geliebter says.
 As important as research is to Drs. Tiwari and Geliebter, their  
commitment to their students is evident to all who know them. 
“They’re very nurturing to medical students and residents,” says  
Steven D. Schaefer, M.D., professor and chairman of the Department 
of Otolaryngology.
“We have a lifelong, personal commitment to education,” Dr.  
Geliebter says. “Raj has to make sure that all 40 postgraduates in 
microbiology and immunology are doing productive work, that  
they’re moving along, that their projects will take them to a thesis.”
“Our vision for translational research in cancer, as well as our teaching 
philosophies, match each other’s very well,” Dr. Tiwari says. “We are 
not only academicians—we feel we should leave a legacy of our  
vision with the younger generation.”
Separate paths, similar values
The understanding and enthusiasm that Drs. Tiwari and Geliebter 
share for each other’s work can be traced, at least in part, to their 
arrival at the College within a month of each other, in 1996. Dr.  
Geliebter received his bachelor’s degree from Hebrew University  
in Jerusalem, followed by a doctorate from SUNY Downstate in 
Brooklyn. He did a post-doc at Albert Einstein College of Medicine 
and was on the faculty at Rockefeller University and at Einstein.
After obtaining his Ph.D. from Calcutta University, Dr. Tiwari completed 
postdoctoral training at the University of Toronto’s department of 
immunology. He then went to Memorial Sloan-Kettering, where he 
served on the molecular biology faculty from 1989 until 1992. From 
there he moved over to the faculty at Cornell University, where he 
“We are not only academicians—
we feel we should leave a legacy 
of our vision with the younger 
generation.”
– Raj Tiwari, Ph.D.
Over-expression of ALOX-5 
Enhanced expression of the gene ALOX-5 increases invasiveness of thyroid cancer 
cells. The panel on the right shows increased invasion of thyroid cancer cells (magenta) 
across a filter, digesting tissue matrix and migrating through holes (black spots on 
filter), due to over-expression of ALOX-5. The panel on the left shows thyroid cancer 
cells with a low level of ALOX expression. ALOX-5 over-expression induces the cancer 
cells to produce enzymes that degrade tissues and allow cells to spread. Images 
courtesy of Jan Geliebter, Ph.D.
Invading Stem Cells  
In this pair of slides, stem cells 
invade goiter nodules to initiate 
formation of new blood vessels. Slide 
at top shows normal cells.  At right, 
arrows point to new blood vessels 
being formed in response to the 
tumor. Merged yellow and green 
markings are the stem cells from 
bone marrow that are initiating new 
blood vessels. These are potential 
targets of therapy to prevent 
formation of new blood vessels that 
help the cancer to grow. Images 
courtesy of Raj Tiwari, Ph.D.
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Intramural collaboration with  clinicians in the Department of Otolaryngology has been essential 
to the thyroid cancer research of Dr. 
Geliebter and Dr. Tiwari.
Steven D. Schaefer, M.D., professor  
and chairman of the Department of  
Otolaryngology, collaborated with the 
researchers on the pre-clinical DIM 
paper (see main story), and recently 
decided to grant them intramural  
funding from his department for two 
new studies of thyroid cancer—one 
involving gene expression, the other  
immune markers. 
“Their studies intersect with the interests 
of this department, so it was a good fit,” 
Dr. Schaefer says. “They’re both good 
scientists, producing results all the time, 
and they’re a pleasure to work with.” 
Their research into molecular markers 
of papillary thyroid cancer began when 
Stimson Schantz, M.D., Dr. Schaefer’s 
colleague at The New York Eye and 
Ear Infirmary (NYEEI), explained to 
them that in 20 percent of biopsy 
samples, it’s impossible to tell 
whether or not cancer is 
present, and so surgery to 
remove the whole gland 
must be undertaken as a 
precaution. 
“Remember the old Star 
Trek and the ‘prime 
directive?’” Dr. Geliebter 
says. “We were given a 
prime directive by Dr. 
Schantz: find a molecular 
marker for thyroid cancer.”
In a paper published in 2006 in the 
Journal of Proteome Research, Drs. 
Tiwari, Schaefer, Geliebter, Schantz and 
others described how they combed 
through thousands of potential  
biomarkers. Using proteomic tech-
niques, they settled on a constellation 
of 63 that together correctly identified  
a non-cancerous sample that had  
previously been labeled suspicious.
“There is a lot of virtue in trying to find 
markers in the overall genomic and 
proteomic profile,” Dr. Tiwari says.
The collaboration between clinicians at 
the NYEEI and the College is whole-
heartedly endorsed by the chairman of 
the Department of Microbiology and 
Immunology, Ira Schwartz, Ph.D. 
“The most important aspect of  
medical research today is translating 
basic scientific findings into clinical 
practice,” Dr. Schwartz says. “As a  
basic science department, we need to 
collaborate with clinical departments to 
bring research from bench to bedside. 
Fortunately we’ve found a very willing 
partner in Dr. Schaefer and his group at 
New York Eye and Ear. It’s developed 
into a wonderful collaboration.” 
Drs. Geliebter and Tiwari credit Dr. 
Schwartz with fostering an atmosphere 
where collaboration is valued, and 
shower praise on the clinicians at 
NYEEI. 
“I have to emphasize how helpful the 
people are at New York Eye and Ear—
not just the attending physicians and 
residents, but everyone, from physician 
assistants and nurse practitioners to pa-
thologists,” says Dr. Geliebter. “It’s rare 
to have that kind of cooperation. And 
they recruit faculty who are interested in 
research. It’s really an ideal situation.”
— Dan Hurley
Making Good on the Promise 
of Intramural Collaboration
remained until coming to the College. 
Despite their different starting points, 
“we quickly realized we shared an  
interest in the molecular basis and 
chemoprevention of cancer,” Dr.  
Geliebter says. “You can’t be an island 
in science. And it’s easier to get funding 
when there’s more than one researcher 
involved. In Brooklyn we call it more 
bang for the buck.”  
One more thing the two researchers 
share: enormous respect and admira-
tion for their colleagues. With little 
prompting, they will list more than  
25 colleagues, including post-docs, 
M.D./Ph.D. and grad students, otolar-
yngology residents, physician assistants, 
pathologists and nurse practitioners 
who contribute to the work. But they 
reserve a special regard for the two 
department chairs who have opened 
so many doors.
“It would be very tough without a 
chairman who supports this kind of  
collaborative environment,” says Dr.  
Tiwari. “The Department of Otolar-
yngology under Steve Schaeffer has 
shown a remarkable commitment to 
research. They respect research and  
the people who do it.” p
When basic scientists and clinicians come together on a 
research endeavor, the goal is to apply discoveries gener-
ated through basic scientific inquiry to the treatment 
or prevention of disease. Nobody knows this better than 
Steven D. Schaefer, M.D., professor and chairman of the 
Department of Otolaryngology and head of the resi-
dency program at The New York Eye and Ear Infirmary. 
A clinical researcher, he not only collaborates with bench 
scientists, he also supports their work with funding from 
his own department. 
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Before the actor Michael J. Fox gave a face and a poignant backstory to Parkinson’s disease (PD), research into the motor system disorder was as inconspicuous as the 
neurodegenerative illness in its earliest stage—the years before 
the telltale symptoms of tremor, rigid limbs and slow movement 
begin to appear. Thanks to the actor’s foundation for Parkinson’s 
research and his passion to maneuver PD to the front burner, 
the disease has caught the fascination of a new breed of scientists 
who are eager to combine its long history of significant discover-
ies and disappointing outcomes with the promises of molecular 
biology and stem cell therapy to find a cause and cure. 
Zhongtao Zhang, Ph.D., an assistant professor of biochemistry 
and molecular biology, is a basic science pioneer who stands by 
the conviction that to understand the enigma that is Parkinson’s 
disease depends on finding out why the dopamine-producing 
brain cells (neurons) are disappearing from the area of the brain 
known as the substantia nigra. Dopamine is a neurotransmitter 
that helps to relay messages that control body movement.  As 
the chemical is depleted, the lives of PD sufferers slowly diminish 
as the chronic illness progresses toward a debilitated end. In 
some 30 percent of cases, there is mental deterioration as well.
After Zhongtao Zhang received his Ph.D. in biochemistry from Purdue 
University, he did cancer research as a post-doc at Yale and NYU.  
Then he decided to study the other end of the cell growth process— 
neurodegeneration—and trained his sights on Parkinson’s disease. 
A biochemist pinpoints  
dopamine oxidation as the 
cause for brain cell death  
and depletion of the  
neurotransmitter that  
characterizes the disease’s  
early stages.
By Marjorie Roberts
ZHONGTAO ZHANG, PH.D., 
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By the time a patient’s symptoms appear,”  
Dr. Zhang advises, “70 percent of the neurons 
delivering dopamine have died. What we have 
to do is figure out how the degeneration 
starts and then slow it down enough for  
patients to live to the age of 90.” Slightly 
more than half of the 50,000 new cases  
reported annually are men, and the average 
age of PD onset is 60. A small percentage  
of cases are clearly inherited, but in most  
instances, they are not. The National  
Parkinson’s Foundation estimates that Parkin-
son’s affects one million Americans, ranking 
it second only to Alzheimer’s disease in 
incidence of neurological disorders. Dr. Zhang 
does not think the correlation is coincidental.
Partners in crime
“I believe Parkinson’s and Alzheimer’s are 
related. When you find a solution to one 
you will have solved the other,” he says flatly. 
He dismisses some purported causes that 
have held sway from time to time, such as 
aluminum cookware, use of pesticides and 
abstaining from coffee.
If his research commitment over the last 
decade is any indication, Dr. Zhang is making 
headway. Before the term of his first NIH 
grant for $1,443,000, “Structure/Function 
Studies of quinone reductase 2,” ended in 
March, Dr. Zhang had applied for another 
NIH award. The first study confirmed his  
hypothesis that research in PD must begin 
with controlling the dopamine oxidation 
that is killing the neurons. “My laboratory 
discovered that an old enzyme, quinone 
reductase 2, is regulating dopamine oxidation. 
Many pieces are still missing, but if we can 
figure out how to slow the process down, we 
can eventually retard the progression of the 
disease,” he says. Assisting him in the project 
were Yue Fu, a Ph.D. student who graduated 
in 2008, and a post-doctoral fellow, Leonid 
Buryanovskyy, Ph.D., who is still working in  
his laboratory.
“Dopamine-producing neurons preferentially 
get degenerated in Parkinson’s disease,” Dr. 
Zhang explains. “Perhaps it’s because these 
neurons contain the most dopamine. As a 
chemist, I took a close look at the chemi-
cal properties of dopamine and its related 
neuron transmitters—norepinephrine and 
epinephrine. These chemicals are especially 
sensitive to oxidation, and the oxidation 
products are very reactive and toxic. I rea-
soned that our body must have many ways 
to defend against the toxins and failure of 
any of the defense pathways will result in the 
early onset of neurodegenerative disorders.”
The new grant would support further  
investigation of three of eight Parkinson-
related proteins that have been discovered 
by other laboratories over the last decade. 
“These are important proteins that are  
defending against dopamine oxidation, but 
we don’t know exactly how they do it,” he 
says. Dr. Zhang has elected to study alpha- 
synuclein, a major component of Lewy 
bodies, which are abnormal aggregates of 
protein that develop inside neurons and 
eventually displace other components of the 
cell. He considers alpha-synuclein a major 
contributing factor to neurodegradation. 
Critical proteins
His second target is called DJ-1; its purpose 
is undetermined, though it is considered es-
sential to the human body. The third  
protein is Parkin, also known as ubiquiton 
ligase, which he calls “the garbage disposal  
responsible for the degradation of junk proteins 
in the cell.” He is trying to determine what 
type of damaged proteins Parkin is seeking. 
Basic scientists often disparage clinical concerns 
in favor of pure science in their research, but 
Dr. Zhang is not one of them: “I am going 
to stick with Parkinson’s because I believe 
age-related diseases have the most impact 
on society. They are expensive to treat, both 
economically and socially.” His initial research 
interest was cancer, and he accepted fellow-
ships to study receptor proteins with Dr.  
Joseph Schlessinger, first at New York Univer-
sity Medical Center and later at Yale. Dr. Zhang 
began his long road to a Ph.D. with an under-
graduate degree in chemistry and education 
—“I was trained to be a chemistry teacher,” 
he says— from a university in Shanghai, China, 
followed by a master’s degree in organic 
chemistry from Beijing Medical University.
He graduated in 1989, the same year he 
decided to come to America for his Ph.D. 
In 1994 he received his doctoral degree in 
biochemistry from Purdue University, where 
he had started researching protein tyrosine 
phosphatase—fascinated, he says, by cellular 
signal transduction pathways, especially protein 
phosphorylation and dephosphorylation. In 
2002, after the post-docs were completed, he 
accepted an assistant professor appointment 
at New York Medical College.
“I believe Parkinson’s and Alzheimer’s are 
related. When you find a solution to one 
you will have solved the other.” 
– Zhongtao Zhang, Ph.D.
In his quest to slow down the neuronal degeneration 
that is the hallmark of Parkinson’s disease, Dr. Zhang 
focuses on proteins already linked to the movement 
disorder. At left is a graphic of the enzyme quinone 
reductase 2 in complex with dopamine (red spheres), 
which he believes is key to retarding the process.  At 
right is the enzyme DJ-1, a key protein against oxidative 
stress that can lead to Parkinson’s when it undergoes 
certain genetic mutations. Images courtesy of Zhongtao 
Zhang, Ph.D.
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“Many pieces are still missing, but if we can  
figure out how to slow the process down,  
we can eventually retard the progression of  
the disease.”       
– Zhongtao Zhang, Ph.D.
Opposing forces
Dr. Zhang’s background has given him a leg up 
on Parkinson’s disease. “Neurodegeneration 
and cancer are at the opposite ends of the cell 
growth process. Neurodegeneration is caused by 
early cell death, whereas cancer is the result of 
uncontrolled cell growth,” he explains. “It is a fact 
that PD patients have a significantly reduced risk 
of several cancers, including lung and prostate. 
However, they also have a slight increase in risk 
for brain, melanoma and breast cancers. The 
question is, if we find something to prevent PD 
and AD, will it increase the risk of cancer? At this 
point I just don’t know the answer.” 
While there still is no drug that can cure, delay, 
prevent or reverse the course of Parkinson’s 
disease, there are therapies that relieve 
symptoms—at least for a while, until they 
stop working. Levodopa (L-dopa) was 
discovered 40 years ago and remains the 
gold standard of treatment—but at a price. 
It is the precursor of dopamine, taken up by 
nerve cells to make dopamine and replenish 
the brain’s dwindling supply. But it does nothing 
to halt the continuing death of the brain’s 
remaining neurons. What’s worse, Dr. Zhang 
believes L-dopa may even be accelerating 
their demise. In any case, in five to ten years 
the neurons are no longer responsive to 
treatment. 
Periodically, another drug or treatment 
emerges in the Parkinson camp and causes 
some excitement. Dopamine agonists like 
Mirapex and Requip, which can substitute for 
dopamine quite effectively, are now standard 
treatment. But eventually they stop working, too. 
Alleviate symptoms 
Gaining in popularity is a surgical procedure 
called deep brain stimulation (DBS) that is 
remarkably effective at alleviating the tremors 
and flailing movements (dyskinesia) that steadily 
worsen as the dopamine fades away.
As for the stem cell approach touted by  
Michael  J. Fox, Dr. Zhang does not have  
much confidence in it as a cure, although his 
open mind dictates that he go wherever his  
experiments take him.
“People, especially scientists, make everything 
very complicated and they often miss the  
obvious, the simple things.” he says. “My goal is 
to find something cheap enough for PD patients 
to use until the day they die.” Certainly, he 
asserts, there will be a need. “Parkinson’s and 
Alzheimer’s diseases go hand in hand with aging, 
and getting them may be inevitable if you live 
long enough.”p
Protecting the  
Fragile Baby Brain
Neonatologist and researcher Praveen Ballabh, M.D., is 
discovering possibilities for preventing brain hemorrhages  
in vulnerable preterm infants.
By Cynthia A. Read
Medicine’s ability to save even the  tiniest premature babies—those weighing less than 1,000 grams  
(about 2.2 pounds) and born as early as 23 
weeks—is a scientific miracle. What was once 
almost unimaginable is the fact that now 85  
to 90 percent of these infants survive. But  
the miracle often comes at a high price.  
Fragile blood vessels in the immature brain 
frequently rupture with damage from the 
hemorrhage causing devastating complications: 
hydrocephalus, cerebral palsy and mental  
retardation. While parents of these tiny,  
vulnerable infants may have prayed for their 
children to survive, they probably did not 
realize that it may come at the cost of brain 
hemorrhage, the most common neurological 
problem in premature infants. 
Praveen Ballabh, M.D., associate professor of 
pediatrics in the Division of Newborn Medicine, 
wants to improve the odds for these micro-
premies. Since coming to New York Medical 
College in 2001, he has been researching the 
causes of germinal matrix hemorrhage (GMH), 
which occurs in up to 20 percent of preterm 
infants born at less than 1,500 grams. With a 
steely determination belied by his gentle eyes 
and lilting voice, he is tracking ways to prevent 
GMH and to mitigate its dreadful effects.
At right:  As principal investigator on NIH-funded stud-
ies of the delicate mechanisms of the newborn brain, 
Dr. Ballabh (center) relies on his team. From left they 
are: Caroline Chua, M.D., neonatal-perinatal fellow; 
Govindaiah Vinukonda, Ph.D., instructor of pediatrics; 
Muhammad T. Zia, M.D., assistant professor of pediatrics; 
Krishna Dummula, M.D., neonatal-perinatal fellow; and 
Furong Hu, research associate.
Neonatologist, researcher
Dr. Ballabh was trained as a general  
pediatrician at the Institute of Medical Sciences, 
Varanasi, India. After coming to the United 
States to study pediatric critical care, he  
decided to specialize in neonatology. Although, 
he observed, “In general, neonatologists are 
more focused on clinical issues than on  
research,” he thought he could be both 
creative and productive in this field. During a 
neonatal fellowship at The New York Presbyte-
rian Hospital-Weill Cornell Medical Center, his 
first studies focused on chronic lung disease in 
premature infants. It quickly became obvious, 
however, that although you could fix the lungs 
of a newborn, the brain was another matter. 
“The baby might survive,” he comments, “but at 
what cost, if the parents were left with a child 
seriously damaged by a brain hemorrhage?”
Usually occurring in the first 72 hours after 
birth and primarily in extremely premature 
newborns, brain hemorrhages affect nearly 
12,000 newborns each year in the United 
States. They originate in the germinal matrix, a 
temporary structure around the cavity of the 
brain in all developing fetuses. Neurons  
and glial cells originate in the germinal matrix 
and migrate out to form the cerebral cortex 
of the brain. Rich in blood vessels, the  
germinal matrix slowly regresses in the baby’s 
maturing brain and almost disappears by 
36 weeks gestational age. But if the baby is 
born prematurely, the germinal matrix is still a 
looming presence—and it bleeds with alarming 
ease. If the hemorrhage is substantial, it spreads 
into the brain’s ventricles; doctors call this an 
intraventricular hemorrhage (IVH).
Group effort
Dr. Ballabh collaborated with Maiken  
Nedergaard, M.D., D.M. Sc., a former faculty 
researcher now at the University of Rochester. 
He began to explore why the blood vessels in 
the germinal matrix are so fragile and porous. 
Their research focused on vascular density—
the germinal matrix has two to three times 
more vasculature than the cerebral cortex—
and on the cellular structure of the germinal 
matrix blood vessel. Papers were published in 
Neurobiology of Disease and Pediatric Research.
With NIH grant support, Dr. Ballabh  
re-focused his attention on angiogenesis, the 
process by which new blood vessels are  
created. Angiogenesis is primarily influenced  
by two molecules, vascular endothelial growth 
factor (VEGF) and angiopoietin-2, both of which 
cause rapid proliferation of blood vessels in 
humans and in animal models. He and his team 
evaluated angiogenesis in postmortem brain 
tissue, both human and animal, and observed 
active vessel growth in three comparative 
models. They also found that VEGF, angiopoi-
etin-2, and endothelial cell proliferation were 
consistently higher in the germinal matrix  
relative to the rest of the brain.
If angiogenesis in the germinal matrix could be 
slowed or halted close to the time of preterm 
delivery, Dr. Ballabh hypothesized, perhaps 
there would be fewer new blood vessels 
susceptible to the stress of birth and adjusting 
to life outside the uterus and, consequently, 
fewer hemorrhages. Various drugs have been 
shown to reduce angiogenesis in tumors, 
The germinal matrix (GM) is made up of prema-
ture neurons and glial cells (green), enriched with 
blood vessels (red). Nuclei of neuronal and glial 
precursors are stained blue. Unlike blood vessels 
in other parts of the brain, GM vasculature is 
especially vulnerable to hemorrhage. When the 
hemorrhage is substantial, blood leaks into the ven-
tricle (appearing here as a black cavity), resulting in 
intraventricular hemorrhage. Confocal microscopy 
showing brain section of a 24-week premature infant 
courtesy of Praveen Ballabh, M.D.
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“The research would be impossible  
without teamwork. My team members  
have contributed as much as I have.”
        – Praveen Ballabh, M.D.
Pursuing prevention
While continuing to pursue this line of  
investigation, with the eventual goal of a clinical 
trial testing the use of celecoxib in pregnant 
women as a preventive, Dr. Ballabh and his 
group are investigating other possibilities for 
preventing or minimizing brain damage after 
the development of GMH and IVH. In working 
with rabbit pups, he believes they have hit 
upon an excellent animal model for IVH. If he 
induces hemorrhage in these preterm rabbit 
pups at birth, by the end of two weeks 25 
percent will have motor problems that mimic 
cerebral palsy, and 44 percent will have hydro-
cephalus. Their research, called “revolutionary” 
by Edmund F. LaGamma, M.D. ’76, director of the 
Division of Newborn Medicine at the College 
and the Regional Neonatal Center at the hospital, 
is under review for publication.
There are five members on the team, each 
with expertise in a specialized area. Neona-
tologist Muhammed Tahir Zia, M.D., assistant 
professor of pediatrics, is particularly interested 
in oxidative stress, while genetics and the 
gene detection of molecules are the focus of 
Govindaiah Vinukonda, Ph.D., an instructor in 
pediatrics. Two neonatology fellows, Krishna 
Dummula, M.D., and Caroline Chua, M.D., who 
is skilled in using head ultrasound to diagnose 
IVH, are emerging neuroscientists. Furong Hu, a 
pharmacy graduate from China, is in charge  
of the premature rabbit pups. Dr. Ballabh  
emphasizes, “The research would be impos-
sible without teamwork. My team members 
have contributed as much as I have.”
Dr. Ballabh received $187,625 from Pfizer to 
study the postnatal use of celecoxib in their 
rabbit model. Giving this drug to newborn 
rabbit pups appears to decrease neuronal 
death after the brain bleeds, so he is inves-
tigating whether this will also reduce the 
incidence of cerebral palsy. While these studies 
are ongoing, Dr. Ballabh is seeking another 
NIH grant to continue his research.
A promising alternative to the celecoxib 
approach is the use of apocyanin, a NADPH 
oxidase inhibitor. Supported by an intramural 
grant awarded to Dr. Zia, Dr. Ballabh and his 
team collaborated with colleagues in the  
departments of Physiology and Pediatrics on a 
paper for Stroke (now in press) showing that 
apocyanin reduces cell death in premature 
rabbit pups with brain hemorrhage. Another 
intramural grant, this one awarded to Dr. 
Vinukonda, will enable the group to explore 
protective interventions after IVH.
Support from the Division of Newborn 
Medicine, along with a two-year, $100,000 
grant from Maria Fareri Children’s Hospital 
Foundation, is financing the research of cell 
surface proteins (integrins) in the germinal 
matrix and in the brain tissue in other parts 
of the brain as well. Because integrin beta-2 is 
critical to embryonic angiogenesis, inhibiting 
its expression might be a way to suppress the 
growth of blood vessels, thus reducing the 
chance of GMH. 
Holding a vision
Like all dedicated researchers, Dr. Ballabh 
must make considerable sacrifices in his 
personal life to pursue his research goals. He 
rotates into clinical service at the children’s 
hospital for two to three months a year and 
is frequently on call. He is always teaching, 
whether at the conferences, in the hospital, 
or with fellows in his lab, whom he says he 
drives very hard. 
His objective in everything he does is “to 
make life better for the babies.” By hunting 
down better ways to protect their vulnerable 
brains from bleeding, he holds the vision of a 
day when he will never again have to “wipe 
away the tears of a mother after I’ve told  
her that her baby’s chances are slim  
because he has a major hemorrhage all 
through his brain.”p
including celecoxib, a selective COX-2 inhibitor 
primarily used to treat arthritis, menstrual 
pain and certain tumors. So Dr. Ballabh and 
his team tested prenatal treatment of rabbits 
with celecoxib and with a VEGF inhibitor, 
ZD6474. What they found is that it not  
only decreased VEGF, angiopoietin-2, and  
endothelial cell proliferation, it also decreased 
the incidence of a moderate or severe GMH 
by half—from 90 percent to 45 percent. Their 
research was published in Nature Medicine 
in 2007, with a follow up study published in 
2008 in the Journal of Neuroscience.
An important question, Dr. Ballabh points 
out, is whether it might be risky to stop the 
formation of new blood vessels in the baby 
brain. But the pharmaceutical intervention he 
has been investigating must be administered 
within three days before delivery, shrinking 
the window of risk. Moreover, a small study 
by another group has already safely used 
celecoxib to slow preterm labor in pregnant 
women. His third point of fact is that once an 
infant is born—whether at 24 or 30 weeks—
the increased oxygen in its system upon 
exposure to room air naturally suppresses 
angiogenesis. For a neonatologist who has 
seen his share of grieving parents, he hopes 
to discover that the treatment is worth  
the risk.
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seamlessly they work together, chalking up one success after another 
with each endeavor.
Leonard Newman has a CV that should be enshrined for viewing by 
every applicant interviewed at New York Medical College.  With the 
exception of an internship at University Hospital of San Diego County 
in California, and a fellowship in pediatric gastroenterology and nutri-
tion at Albert Einstein College of Medicine in the Bronx, Dr. Newman 
has spent every year of his professional life with the College—both 
on the Valhalla campus and in New York City, when the College was 
located at Flower and Fifth Avenue Hospitals. Asking what else there  
is to accomplish elicits a heartfelt answer that evinces something he 
can’t control: “Just leave us alone. No more cutbacks.” In this time of 
unprecedented economic stress then, is it perhaps time to get out?          
“I enjoy what I’m doing, but I might retire in three, four or five years,” 
he says, with a near dead-pan that implies he isn’t serious about  
stepping down at all.
Future is now
Dr. Newman knows what it takes to make a department run smoothly, 
but the economic treadmill is a tough opponent.  “No one is desper-
ate to come to this part of the country, and the cutbacks make it 
worse,” he says. “To get good people you need to recruit, and there is a 
process. My wish is to keep the good people I have, and to keep them 
satisfied. We are also trying to increase research in the department, 
and programs are impacted when dollars are cut. It’s a problem all over 
the country, especially in pediatrics.
“There was a time when we were worried about survival. It’s not like 
that now, even though things are tough all over.  But I don’t think the 
hospital ever had the so-called good old days,” he continues. “There 
was always turmoil of one kind or another.  Times would get better  
but then turn dicey when government cuts removed support.  
No schizophrenia here...  
it’s all about two pediatricians 
who have made taking care  
of children their life’s work.
By Marjorie Roberts
Leonard J. Newman, M.D. ’70, and  Michael H. Gewitz, M.D., think alike. This surely accounts for what they 
have accomplished for their constituency—
the children of the seven-county lower 
Hudson Valley, and areas in neighboring 
Connecticut and New Jersey. First class 
facilities and a team of specialists second to 
none are the achievements of Dr. Newman, 
chairman of the Department of Pediatrics at 
New York Medical College, and Dr. Gewitz, 
vice chairman, and physician-in-chief and 
director of the Maria Fareri Children’s  
Hospital at Westchester Medical Center. 
When you speak to them separately they 
often verbalize as one, answering questions 
nearly in identical words and speaking in 
oddly similar cadences. Over and over, as if it 
were the first commandment of evolution, they talk about taking care 
of children, and the listener is left comfortable and satisfied. They both 
continue to see patients, new and old, who keep their doctoring skills 
from getting rusty. What leaves the biggest impression, though, is how 
SPLIT
Leonard J. Newman, M.D. ’70
Michael H. Gewitz, M.D. 
S LI  PERSONALITY: 
Leonard J. Newman, M.D. ’70, and Michael H. Gewitz, M.D.
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good overview of what is needed to run a huge program. That team-
work is essential. You can’t be chairman and also run a major hospital.”
Inspiring teachers
A big what-if in Dr. Newman’s past offers a glimpse into his gut instincts: 
his high school guidance counselor told him he would make a good 
social worker. “No, I really want to be a doctor,” he insisted. Accepted to 
several medical schools but preferring to be in Manhattan, he chose the 
College because “the people I met from Admissions were wonderful.” 
And so, after an undergraduate degree from Rutgers University in his 
home state of New Jersey, Dr. Newman began his love affair with  
New York Medical College. Helping him to decide on pediatrics and 
gastroenterology were two “inspiring teachers in my junior year  
rotation,” he says: the late Edward Wasserman,  M.D. ’46, former chair  
of the department, and George D. Rook, M.D. , former professor of  
pediatrics. For his fellowship, Albert Einstein beckoned: the renowned 
Still, we are optimistic.  The opening of the children’s hospital satisfied 
a big chunk of my wish list. What I’d really like to see is cooperation 
between Westchester Medical Center, the College and the  
Department of Pediatrics. I’m not sure it ever existed before.”
Dr. Newman prefers to leave discussion of the Maria Fareri  
Children’s Hospital at Westchester Medical Center to its director,  
Dr. Michael Gewitz. He credits Karl P. Adler, M.D., now president 
of the College, with the foresight of putting them in the right jobs: 
“When Karl was dean [School of Medicine, 1987 to 1994], in a 
moment of genius he made me chair of the department and Mike 
director at the hospital. Mike and I have worked together from the 
beginning and have always had a close relationship. He enjoys the 
more administrative and political sides, but he is also a first rate aca-
demician and teacher.  I’m more interested in practice management 
and faculty development, and also in strong academics. We have 
found our niche, but at the core we are both caring doctors with a 
14    Spring/Summer 2009
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Murray Davidson, M.D., was there. “He could be called the 
father of pediatric gastroenterology,” says Dr. Newman.  
“Davidson developed treatments for ulcerative colitis, 
Crohn’s disease and celiac disease.”
Dr. Newman delights in taking credit for marketing the 
hospital practice to local pediatricians, who initially feared 
competition “from Valhalla” when the College moved up 
from New York City. As he continued to recruit stellar chiefs 
for sections that range from endocrinology to neonatology 
to immunology and infectious diseases, the word began to 
circulate: send your really sick children to Westchester. “The 
goal of the Department of Pediatrics is still the same: to be 
a resource for children in the seven counties and beyond,” 
says Dr. Newman. “Mike Gewitz and I have the same desire 
to provide this excellent care and by all measures, I think we 
have succeeded.” 
“The goal of the  
Department of  
Pediatrics is still the 
same: to be a resource 
for children in the  
seven counties and  
beyond. Mike Gewitz 
and I have the same 
desire to provide this 
excellent care and by 
all measures, I think  
we have succeeded.”
- Leonard Newman, M.D. ’70
The making of a hospital
They spend most of their work days supervising 200 full-time faculty  
pediatricians, 100 of them on campus. Since 2004 the primary location  
is the Maria Fareri Children’s Hospital, a stunning architectural showpiece 
filled with stuff that kids love, like a real locomotive, a wall of furnished 
dollhouses, a baseball museum and a gigantic aquarium to explore. Oh, 
and it also boasts state of the art technology and some of the best doctors 
in the Hudson Valley, making it the leading choice for the care of children 
and their parents who can stay overnight with them if they desire.  
Built on such a grand scale, it is hard to believe the space is already too 
small—by 30 percent, Dr. Gewitz advises. “It is frequently over capacity, 
something we predicted during the planning. But the consultants we were 
using then voted us down,” he says, adding slyly, “The new consultants 
agree with us.” If it is unseemly to call something a success that is built 
because of the needs of sick children, one should remember that it was 
the death of one young girl that provided the impetus in the first place.
After their daughter Maria died in 1995 at Westchester Medical Center, 
where she was moved when a community hospital was unable to diag-
nose her deadly condition as rabies, John and Brenda Fareri offered the 
motivation and momentum to create one of the first children’s hospitals 
designed solely for children and families, and only one of four freestanding 
acute care children’s hospitals in the state.  “The Fareris became involved 
because they felt the top notch medical care we provided should be 
delivered in a better environment, having experienced the deficiencies  
of the original building and the absence of facilities for families to stay,” 
says Dr. Gewitz. 
“Sometimes around here we have a tendency to snatch defeat from the 
jaws of victory. My colleagues and I, along with the key support from the 
Fareris and families throughout the region, worked very hard to see this 
project through. In fact, writing a book about the trials and tribulations of 
the academic health center that is Westchester Medical Center/New York 
Medical College is something I threaten to do in retirement, along with 
playing with my grandchildren and still contributing to the education of 
future doctors.”
Full time job plus
Michael Gewitz has helped to take pediatric cardiology around the 
world—as far as El Salvador and Ukraine. As professor and vice  
chairman of the College department, and chief of pediatric cardiology 
and physician-in-chief/executive director of the hospital, he has not had 
time lately for such things as travel. Even his weekend social life revolves 
around honoring colleagues and other fundraising events that come with 
the territory. He qualifies for the best and that is what he gives; starting 
with his training, it’s the way he’s lived his life.
Brooklyn-born Mike Gewitz received his undergraduate degree from Yale 
in 1970, and his medical degree from Hahnemann Medical College in 
Philadelphia. Internship and residency were at Children’s Hospital of  
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“Lenny and I are pretty symbiotic.  
Our partnership has allowed us  
to make the most of our talents.”
– Michael Gewitz, M.D.
Philadelphia (CHOP), the oldest facility of its 
kind in America. He finished residency as a 
CHOP representative to The Hospital for Sick 
Children in London, the oldest one anywhere. 
Then he returned to Yale for an NIH sponsored 
fellowship in pediatric cardiology. In 1979 Dr. 
Gewitz began his attending career at CHOP 
and the University of Pennsylvania School of 
Medicine. He left as an assistant professor  
after five years to join the College as associ-
ate professor, and was appointed chief of the 
section of pediatric cardiology at the medical 
center. In 1989 he was promoted to full  
professor, and three years later became vice 
chairman of the Department of Pediatrics.
Love of teaching
There are 49 residents and 18 fellows learning 
the trade this year, making Westchester Medical 
Center a top graduate program in pediatrics, 
says Dr. Gewitz. Both he and Dr. Newman 
interact with them and the College medical 
students regularly. “Lenny and I built a team that 
spans the scope of complex medical specialties 
and includes a great primary care group and 
child advocacy program. We have an unbeliev-
able combination of people and programs, held 
together by an entrepreneurial approach within 
an academic medical center.  And we did it in 
the shadow of the New York City giants.  Lenny 
and I are pretty symbiotic. Our partnership has 
allowed us to make the most of our talents.”
Those include patience and perseverance. 
“Working with Lenny means every day is a new 
day. He throws lots of balls into the air and then 
gets out of the way. Lenny has a great capacity 
for thinking outside the box. Sometimes the 
unpredictability of it is challenging. It is always 
interesting,” says Dr. Gewitz. 
When Dr. Newman does retire, what will that 
do to Gewitz’s own plans for the future? There 
is still a lot to be accomplished,” he says. “I’m 
not ready to go yet. We need to expand the 
hospital, expand our research programs, and 
enhance the total capacity of surgical special-
ties. And all the time to continue our mission as 
advocates to upgrade children’s health care in 
the region.” 
 Will that be enough?  The good doctor reveals 
he has taken on the chair-elect position of 
the Council of Cardiovascular Diseases of the 
Young, one of the 13 scientific councils of the 
American Heart Association. “It’s a four-year 
commitment,” he reveals. “I guess I just don’t 
know how to get out of the way.”p
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Please fill out this reader survey and return in the 
envelope provided. If you wish to enclose a donation, 
it will be gratefully appreciated.
1.  Why do you read Chironian? (Rank in order of  
importance)
______ News about alumni
______ News about the College, its activities and progress
______ News about students, faculty, leadership
______ Trends in research and medical education
______ the “State of the University”
______ Other ____________________________
2. How much of each issue do you read?
______Read it cover to cover
______Read or skim about half the articles
______Read only what interests me 
______Read only about people I know
______Don’t read it
3.  Please rate how much you agree or disagree with the  
following statements:
 Strongly             Neutral           Strongly
Disagree              Agree
   1         2      3           4   5
The articles are interesting and informative______
The layout and design make it easy to read ______
The magazine keeps me up to date on alumni ______
The magazine keeps me informed about College  
current events and the state of the university _______
The magazine is one way to learn about trends in  
research and medical education _______
The articles provide a good balance of the technical  





NEW  YORK 
MEDICAL 
COLLEGE
Expand Educational Opportunities – Each year, 
our students assume an increasingly heavy financial  
burden as the cost of a first-rate health sciences  
education skyrockets.
n  Your gift will strengthen our tradition of reducing financial 
barriers for many talented and deserving students.
Enhance Academic Leadership – New York Medical 
College boasts some of the brightest minds working in 
health sciences education and research today. 
n  Your gift will provide the resources needed to continue 
to develop this stellar academic team.
Invest in Campus Infrastructure – The resounding 
success of the Medical Education Center and recently 
renovated Basic Sciences Building lobby demonstrates 
the key role that beautiful and innovative facilities play in 
creating a desirable academic environment.
n  Your gift will help to improve and maintain campus 
facilities at a competitive level. 
Transform Medical Education – Having access to 
new technologies like the successful and popular digital 
curriculum database and multi-specialty patient  
simulators is essential for our students and faculty.
n  Your gift will prepare tomorrow’s healthcare professionals 
for the challenges and opportunities of 21st century 
medicine. 
Please make a gift today. Your support will have an 
extraordinary impact on the College’s future.
As we approach the College’s 150th  
anniversary, we invite you to join the 
many benefactors who are working  
to maintain our tradition of excellence  
in the 21st century by investing in  
the Annual Fund. 
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Students 
SURVEY (continued from other side)
4.  Please rank from 1 to 5 which sections of Chironian  
interest you the most (1= most interest, 5= least interest)
______Research articles  ______University news
______Personality profiles ______Student features 
______Alumni news  ______Milestones  
     (class notes)
5.  On a scale of 1 to 5 (1= very well, 5= not well at all) rank 
each of the following for how well Chironian keeps you 
informed about:
______News about alumni
______ News about the College, its activities and  
accomplishments
______News about students, faculty, or leadership
______Trends in research and medical education
______the “state of the university”
______Other _____________________________________





7.  Which best describes your relationship to New York  
Medical College?
__Alumni (Circle: Medicine, Basic Sciences, Public Health)
__Faculty (Circle: Full-time, Part-Time, Voluntary)
__Student (Circle: Medicine, Basic Sciences, Public Health)
__Staff
__Campus or facility (Circle: Main, WMC, SVCMC, Met, Other)
8. Preferred method of keeping in touch: 
__Mail
__Email
__Social network (Facebook, LinkedIn)
__Other __________________
9. If you could change one thing about Chironian, what would it be?
_________________________________________________
_________________________________________________
18    Spring/Summer 2009
✃
Students 
Three medical students tell how summer research 
fellowships changed their views of medicine—  
and of themselves as future physicians.
By Thomas Orton
A Taste of 
Real World 
Medicine
Any medical school curriculum will immerse students for their first two years in a veritable tidal wave of information—paper and electronic, lecture and small group study, journals and labs. But getting out of the classroom and library to work with a top-flight team of researchers, or to accompany a surgeon on patient 
rounds—these are realities that most medical students can hardly wait to experience.
At New York Medical College, there’s a way to get this training in a hurry: student summer research fellowships. 
Each year, some 50 first- and second-year medical students are awarded fellowships by the Student Research  
Fellowship Program. More than 130 faculty-mentored projects, each lasting 6-8 weeks in the summer, cover a 
broad spectrum of disciplines. On one level the fellowships give extra practice in fundamental skills, such as writing 
patient status summaries or mounting slides. Spending a summer immersed in a project, whether in a clinical setting 
or a basic science lab, can help clarify a student’s career goals and give a welcome jolt of inspiration for the  
remaining years of study. 
Still, the real benefit of a fellowship is the exposure to a field of inquiry, a branch of medicine or an affinity for the 
bench—something totally new or unexpected that ignites a passion they never knew was there. This is how it hap-
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From Westchester to 
West Indies                  
Alberto Distefano 
As if his neurosurgery fellowship at Westchester 
Medical Center (WMC) wasn’t enough of a 
new experience, Alberto Distefano, 24, left his 
fellowship briefly to go on a church-sponsored 
charitable mission in the Dominican Republic. 
There he worked with a medical team in  
La Romana, helping to build a hospital and 
teaching the children of sugar workers on  
the plantations.
Back in the states, Distefano resumed his 
neurosurgery fellowship. In addition to his 
full schedule of second-year classes, he began 
observing brain surgeries at least three days a 
week. “The surgeons let us literally look over 
their shoulders,” he says. “When they were 
using microscopes, they’d show us what they 
were doing on a TV monitor.” 
He was particularly impressed by a procedure 
involving deep brain stimulation of a conscious 
Parkinson’s patient. The surgeon probed the 
man’s brain with electrodes, then asked him to 
describe the sensations. After observing in the 
OR, he accompanied his mentor, Raj Murali, 
M.D., professor and chairman of the Depart-
ment of Neurosurgery, on post-op visits. It was 
heartening to see the extent of some patients’ 
recovery and their gratitude. But, he adds, “it 
was difficult to see patients who were very 
sick and weren’t expecting a good outcome.”
Distefano came to medical school already 
armed with some research experience. After 
earning a B.S. in biological sciences degree 
from the University of Connecticut, he spent 
two years at Yale researching Type II diabetes. 
While he thoroughly enjoyed the experience, 
he now concludes, “Working in a hospital 
makes things a whole lot more interesting.  
It’s a lot more alive.” His summer clinical 
experience impressed him enough to consider 
a neurosurgery specialty, although he is also 
contemplating a specialty in ophthalmology or 
gastroenterology. And research may still be in 
the picture. “When you’re doing research,” he 
says, “you can see how it correlates to people. 
But it’s not as direct as treating patients, where 
the reward is extremely visible and direct.” 
A knack  
for compassion                            
Narissa Small 
Narissa Small, 25, has always been fascinated by 
how people interact. As an undergraduate she 
majored in sociology. “Nothing medicine-related 
at all,” she says with a laugh. “But I was really 
intrigued by theories about why humans get 
along or don’t get along.” 
Small’s summer fellowship took her to Maria 
Fareri Children’s Hospital at Westchester Medical 
Center, where she worked in the Division of 
Newborn Medicine, a subspecialty of pediatrics. 
“I was attracted to neonatology because it’s 
a fast-growing field. It’s also where you get to 
treat the sickest newborns,” she says.
This wasn’t Small’s first exposure to the medical 
center. The daughter of a nurse manager, she 
volunteered in the hospital’s ambulatory care 
unit during high school. After graduating from 
New York University, she spent two years as a 
fellow in the cardiovascular research laboratory 
of former faculty researcher Piero Anversa, M.D. 
Working with his team studying myocardial cells 
in the repair of the heart, she decided her future 
lay in attending medical school and earning her 
place as a member of the Class of 2011.
Those years of exposure to both medicine 
and research benefited her during the summer 
fellowship. Rather than being overwhelmed 
by the hospital’s hectic pace and the rigors of 
working with extremely sick infants, Small found 
herself thriving. After morning rounds, she would 
follow the progress of certain patients, record-
ing information needed for a research project 
conducted by her mentor, Boriana Parvez, M.D., 
professor of pediatrics. The research focused 
on necrotizing enterocolitis, a disorder in which 
parts of an infant’s bowel tissue begin to die. 
While the experience heightened her inter-
est in doing more research, Small found great 
satisfaction from her close contact with patients. 
Working with doctors, she says, “gave me a 
special sense of purpose. Being able to relate to 
the families of sick infants was very intense and 
moving.” Perhaps echoing lessons learned from 
that early interest in human interaction, she 
concludes, “Working with people in a hospital 
setting teaches you a lot about compassion.” 
Psychiatry  
summer                           
Paul Nestadt
Psychiatry has always been of keen interest to 
Paul Nestadt. Accordingly, he followed that  
inclination when applying for a psychiatry fellow-
ship. A bonus: it was being mentored by Spencer 
Eth, M.D., professor of psychiatry, who achieved 
wide renown for his work with 9/11 survivors 
and post traumatic stress disorder (PTSD), and 
one of Nestadt’s heroes. 
At Saint Vincent’s Hospital Manhattan, a College 
affiliate, Nestadt accompanied Dr. Eth’s team on 
daily consulting liaison rounds, evaluating patients 
for conditions like delirium and psychosis. “I’d check 
their charts, make notes and report to the resi-
dents,” Nestadt recalls. “I learned psychiatry’s role 
in the treatment of general hospital inpatients.”
In the afternoons he participated in lab research 
projects at Mount Sinai Medical Center. He also 
worked on several papers, presenting one at the 
College’s 2009 Medical Student Research Forum, 
where he placed second. Once a week, Nestadt 
attended mental health court where psychiatric 
inpatients sued for their release from the hospi-
tal. Nestadt recalls, “At first the judge and lawyers 
seemed so cold and procedural, but they only 
want what’s best for the patients.” 
Though always drawn to research, Nestadt 
admits that “med school was never really on 
my radar when I was younger.” After completing 
undergraduate work in neuroscience at Brandeis 
University, Nestadt, who is 27, returned to his 
hometown of Baltimore to help start a charter 
high school. Eventually he made his way back 
to medicine, working several years with a 
psychiatric research team using magnetic reso-
nance spectroscopy to locate biomarkers for 
depression and PTSD. After that, medical school 
started to make the most sense to him. 
While his fellowship reaffirmed his love of  
research, his work at Saint Vincent’s considerably 
widened his opportunities. “The clinical side of 
medicine has always captivated me a lot more 
than the research side,” he says. “But eventu-
ally I’d like to do a combination of teaching, 
research and patient care.” Matter of fact, that 
trio of interests happens to match the mission 
of New York Medical College. p
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Dr. Graboys was profiled in 
Chironian in 2000 when he was, 
as he describes it, “on top of 






A pediatrician  
and a soldier,  
“Dr. Charlie” brings  
empathy, lollipops and  
healing to sick children  
and young men at war.
Alumni 
W hat keeps Col. Charles Garbarino, M.D. ’78, going back to war? It is the memory of his beloved Uncle Willy, who fought in the Battle of the Bulge, and all the children he has cared for in his 30 years as a 
pediatrician. It is the child within each wounded soldier he treats, 
and what he sees in the eyes of those soldiers.
“These soldiers out there are still young,” says Dr. Garbarino, who 
has served two tours of duty in Iraq and this summer will deploy 
to Afghanistan. “Even the older ones need their hands held. No 
matter what their age, when I hear their stories… I can feel how 
they’re missing their families back home.” He adds fervently, “We 
must tell their stories. We must tell people what war is all about.”
And so he has self-published Pediatrician Soldier, a collection 
of essays about his tours of duty in Iraq and Kuwait. Compiled 
from his emails and diary entries, the book tells how Dr. 
Garbarino left a successful medical practice for a combat 
zone. It provides graphic, eyewitness accounts of war and its 
aftermath, and sings praise to Dr. Garbarino’s “true heroes,” the 
soldiers who do and do not come home and their loved ones, 
including his wife Lydia, who are left waiting. All proceeds from 
the book’s sales will benefit Our Military Kids, an organization 
that funds enrichment activities and tutoring for children of 
deployed and severely injured National Guard and Military 
Reserve personnel.
School of Medicine
Col. Charles Garbarino, M.D. ’78
By Andrea Kott, M.P.H.
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“No matter what their age, 
when I hear their stories…  
I can feel how they’re missing 
their families back home.”
- Charles Gabarino, M.D. ’78
“People don’t know what these soldiers are going through,” Dr. 
Garbarino says. “Here you have your life and I have my life, and 
right now there’s a soldier who’s coming home in a box or who 
is mentally scarred for life.” 
In an entry titled, “Guarding a Road,” Dr. Garbarino writes about 
the risks he encountered every day, as a soldier:  How to hold up 
your hand and tell a vehicle to stop while others have weapons 
pointed at them. Good luck. My hand in the air is going to stop 
a moving vehicle loaded with bombs and insurgents who don’t 
care, who will not stop and who will shoot me as they go by—but 
with my hand still in the air asking them to stop. 
Real heroes 
In another entry, “One Soldier—Never To Return,” he describes 
the anguish of reviewing a dead soldier’s medical records: I 
held in my hands this soldier’s medical record. Here was his 
name and his identification. But I knew nothing of this brave 
individual who gave his life. Then I thought about this soldier’s 
family. Was he married, did he have kids? How was his family 
coping with his loss? So many questions—and yet I could not even 
see his face. All I knew [of him] was a name and number. All I 
could do was cry. 
Dr. Garbarino pays special homage to individuals like the late 
Captain John J. McKenna, who was killed by sniper fire while 
leading a mission. His book also tells the story of Sgt. Daniel 
Tallouzi, the victim of a mortar attack who died in February  
2009 after living for more than two years in an “eyes open” 
coma. “The real heroes are in my book,” he says. “I’m just a 
simple pediatrician and a soldier.” Yet little about Dr. Garbarino 
is simple.
Born and raised in the Bensonhurst section of Brooklyn, he 
grew up, in his words, “lower middle class,” an only child from a 
close-knit family. Outgoing and athletic, an Eagle Scout, a tennis 
player and a member of many clubs, he attended St. Francis 
College on a full scholarship. “First I wanted to be a missionary 
priest, and then I got to know girls better,” he says, chuckling. 
Then he thought seriously about the people he wanted around 
him and the kind of work that would allow him the freedom to 
be the pediatrician he always wanted to be—one who delights 
children with a clown nose, propeller beanie, Mickey Mouse 
shirt and lollipops, the one affectionately known as “Dr. Charlie.”
“I always wanted to be a pediatrician and there was only one 
place I wanted to work: Flower and Fifth Avenue Hospitals,” he 
says of the College’s former home in Manhattan, now College-
affiliated Terence Cardinal Cooke Health Care Center. Inspired 
by two pediatrics professors, the late Harry Dweck, M.D., and 
Marvin Green, M.D., neonatologists who were then teaching at 
affiliated Metropolitan Hospital Center, Dr. Garbarino pursued a 
neonatal fellowship at SUNY Stony Brook, where he also became a 
pediatric emergency physician and a pediatric developmentalist. He 
practiced neonatology on Long Island and later in Lynchburg, Va., 
but felt that something was missing from his life. The wanderlust 
turned him into a medical officer in the U.S. Army with the hope  
of seeing the world.
Mickey and Minnie 
Soon after enlisting, he met and married Lydia Fernandez, an 
emergency room nurse and his wife of 23 years. A woman after 
his own heart, Lydia matched her husband’s wedding attire with 
a Minnie Mouse sweatshirt (he wore Mickey), dungarees and 
sneakers. In 1987, the couple moved to Germany, where they  
lived and traveled around for the next three years. 
Although initially headed for Operation Desert Storm, the war’s 
brevity brought Dr. Garbarino and Lydia back to the United States 
and to Livingston, N.J., where he now shares a pediatric practice 
with Deborah Coy, M.D. He is also an associate in the neonatal 
intensive care unit at St. Barnabus Medical Center in Livingston, 
where he teaches several courses in life support. 
In 2003, Dr. Garbarino became the first New Jersey Army National 
Guard physician deployed in support of Operation Iraqi Freedom. 
Convinced he wouldn’t be coming back, he wrote a letter to Lydia 
asking that she not mourn his death. “I want you to celebrate my 
life, my dungarees, my t-shirt with Mickey, my sneakers,” he recalls 
writing. As he anticipates his next mission, the one that will take 
him to war-torn Afghanistan, he says he is afraid, but not of dying. 
“I look at all these soldiers with missing limbs,” he says. “I’m not 
afraid to die but I’m afraid to come back in pieces.”
He goes, nevertheless, to appease the soldier and pediatrician 
inside him, for the soldiers who are just “big kids” and need his 
humor, empathy, love and lollipops to make them smile, and for 
children everywhere. “Kids are the future,” Dr. Garbarino says. 
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“Dr. Charlie” Garbarino and his wife Lydia
Survival of the Fittest
How one dynamic woman 
plans to change the world, 
one stair-stepper at a time.
By Lynda McDaniel
Elizabeth DeLuca, M.P.H. ’07, grew up enjoying the  carbohydrate-rich foods of her native Cuba. Then one 
day, at an age when other kids are 
still feeding quarters into snack  
machines, she made a conscious 
decision to change her diet. Today, 
she’s one of the most sought-after  
fitness instructors in the Northeast 
and owner of FitWell Group, a  
fitness consulting and management  
company based in Stamford, Conn. 
Sounds like quite a turnaround, but 
for this human dynamo, it’s just  
business as usual.
 “My passion has been health and 
fitness since I was 12 years old,”  
DeLuca says. “As an overweight 
child, I couldn’t compete or partici-
pate effectively in sports, so I started to exercise and eat healthier 
foods so I could be more competitive in school sports. Later, when 
I realized that I wanted to help others create healthy lifestyles, I 
decided I needed an advanced degree in public health.”
In the late 1990s, DeLuca was taking classes in what was then 
known as the Graduate School of Health Sciences, but had not yet 
decided on a concentration. At one point the school offered a career 
workshop, and there she had an epiphany that clarified her vision 
for the future. When the instructor asked, “What would you do right 
now if you could start doing it today?” DeLuca didn’t hesitate.
“That’s when I knew I wanted to run a fitness consulting company. 
One that could create high-quality nutrition and exercise programs 
geared to corporations,” she says. 
For most of us, that vision would take a few years to bring about. 
Not DeLuca. Imbued with her father’s entrepreneurial spirit, she 
incorporated FitWell Group within nine months of that workshop.  
“My family moved to America right after Castro, in the late 1960s 
when I was just a baby,” DeLuca says. “I always remember my  
parents saying that America is the best place to live, work and 
prosper. And I carry that spirit with me.” 
Just two years later, she has 22 employees and a roster of con-
sultants, serving clients such as Legg Mason, Elizabeth Arden and 
Citigroup as well as other corporations, country clubs, institutions 
and private clients in Fairfield and Westchester counties. 
Never a dull moment 
With the business up and running, it would seem like a good time 
for DeLuca to enjoy the fruits of her labors. Not yet. Last Septem-
ber she enrolled in the College’s two-year doctor of public health 
(Dr.P.H.) program in order to take her dream to the next level.
“Once I started working, I knew I wanted to do more,” she says. 
“The Dr.P.H. at New York Medical College is the only program in 
the Northeast that pays so much attention to the social determinants 
of health. Economic and social conditions are crucial to the health 
of everyone, and we all need to be more aware of their impact. 
This degree program, especially now that health care is changing, 
is worth all the time and investment. It continues to inspire me and 
grow my business.” 
DeLuca learned a lot about the positive impact of exercise in the 
workplace from preparing a study for her master’s thesis, “The 
Relationship Between Body Mass Index (BMI) and Health-Related 
Quality of Life Among Participants in a Worksite Fitness Center.”  
In March, she and a fellow doctoral student in the School of Public 
Health, Ihsaam Alim, won first place for their poster presentation  
at a conference on obesity sponsored by the Bronx County Medical 
Society.
“The existing literature shows that exercise in the workplace not 
only breaks the tedium of work, it also reduces absenteeism and 
healthcare costs. Plus it increases morale by helping people feel 
good about themselves and their workplace,” she says. “My study 
showed that employees who participate in a FitWell program report 
more healthy days than those who don’t.”
Back on the job, DeLuca is involved with everything from conceptual 
site designs, master planning and programming to instruction,  
management, and marketing. She also develops dynamic transition-
al programs to help ease reluctant employees into safe and effective 
practices that will help them achieve good health. 
Her busy schedule includes teaching classes at local fitness centers 
as well as at FitWell Group corporate locations. Occasionally she’s 
School of Health Sciences and Practice
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invited to model for fitness magazines 
and videos. And she visits with clients to 
determine special needs, such as coor-
dinating a health fair or a popular event 
she has dubbed Corporate Spa Day.  
“We host Pilates and yoga classes, chair 
massages, blood-pressure screenings, 
body-fat fitness analyses, and mini- 
nutritional consultations,” DeLuca  
explains. “A lot of people sign up for 
these company-sponsored events.  
We promote it as a much healthier  
alternative to the holiday party.”
Heart in her work 
Even with her busy schedule, DeLuca 
finds time to volunteer for the local 
Young Women’s League, helping with 
community and children’s issues. She’s 
also involved in the Boys and Girls Club 
and is a sponsor of an annual 5K run.  
So it’s hard to imagine that she has much 
free time for herself and her husband, 
Louis, who is president of AIM Health 
Plans in New York City. But this holistic 
teacher knows better than to neglect her 
own well being. 
“We live in a beautiful area with wooded 
and open natural spaces where I take long 
walks,” she says. “I love taking Big Blue, 
my 7-year-old, 150-pound Mastiff with me. 
That’s challenging—Mastiffs were bred as 
guard dogs during the Roman Empire, so 
walking is not their thing.” 
As her career vision grows, DeLuca 
isn’t content to confine her goals to the 
corporate setting. She’s ready to take 
on the nation and the world. While she 
values her impact on companies and 
their employees, she wants to contribute 
to improving the health of the entire 
population. 
“I hope that by helping employees 
become healthier, they’ll go home 
and share this information with their 
families,” she says. “But I want to help 
as many people as possible make good 
health a priority, creating a lifestyle with 
better eating and exercise habits. My 
doctorate will enable me to better un-
derstand healthcare policy so that I can 
have a greater impact. My ultimate goal 
is to partner with the new presidential 
administration. Once the White House 
meets FitWell Group, together we can 
make America a healthier place.”p
Continued on page 34
Elizabeth DeLuca, M.P.H. ’07
Perpetual 
Learner
                         By L.A. McKeown
Alumni 
Graduate School of Basic Medical Sciences
Jay S. Pattumudi, J.D., M.S. ’98 
Have you ever seen a really cool new invention and wondered how in the world you patent something like that? Well, if you’ve got questions, Jay Pattumudi, J.D., M.S. ’98, is your go-to guy. 
“It’s true. I love what I do,” he says with a laugh. 
As a patent attorney, Pattumudi is part of the behind-
the-scenes work that takes an invention or device from 
the inventor’s hands to the public. He first became 
curious about this specialized field of law while studying 
biochemistry and molecular biology in the Graduate 
School of Basic Medical Sciences. One of his favorite 
professors in the department was Ira Schwartz, Ph.D., 
now professor and chairman of the Department of 
Microbiology and Immunology, who he says “conveyed 
an infectious enthusiasm for molecular biology.” While 
Pattumudi always enjoyed science and liked to write, he 
also sensed that life as a researcher wasn’t for him. He 
soon began to see a problem that few researchers think 
about, or may even be aware of, until after they begin 
publishing their research. 
“Some of the aims of patent law may be in conflict with 
how researchers operate,” Pattumudi says. “For example, 
under U.S. patent law, you are precluded from a right 
to a patent if you have published a paper on the same 
invention more than one year prior to filing the patent 
application.” 
He continues, “It made me realize that faculty and 
graduate students at research universities should be 
educated about the innate conflict between what 
operates in patent law and what operates in research,” 
Pattumudi says. “By their very nature, researchers are 
in the business of sharing knowledge and are thus very 
eager to share such information.” Conversely, patent law 
aims to provide exclusive rights to the person seeking 
the patent and to exclude others from violating those 
rights. Someone like Jay Pattumudi, with his first-hand 
experience in the world of academic research, can help 
scientists and inventors navigate these complexities, 
resulting in greater protection of their rights.
Taking a different path 
Intrigued by the intricacies of patent law and how they 
relate to the research community, Pattumudi changed his 
career path after getting his master’s degree. He went to 
work as a patent clerk for a small law firm in New York 
City that prepared patent and trademark applications for 
research universities, corporate clients, small chemical 
companies and biotechnology firms.  “I assisted the 
patent attorneys with writing applications and doing 
patent searches. I just wanted to get a feel for patent 
law so I could be sure it was the right career for 
me,” Pattumudi says.
While attending the University of Wisconsin Law 
School, he worked as a law clerk for a Wisconsin 
law firm and several government agencies, 
including the U.S. Department of Energy, before 
receiving his law degree in 2002. Eventually he 
moved to Tampa to take a position as an associate 
at Fowler White Boggs Banker, one of the oldest 
and largest law firms in the state. It was there that 
he experienced first-hand the kind of problems 
researchers can face if they are unfamiliar with 
patent law.
He elaborates: “Some academic researchers are 
unaware that their own actions can jeopardize 
their patent rights. For example, European patent 
law, even stricter than the U.S., generally forbids a 
researcher from filing a patent application from the 
moment he or she publishes a research paper on 
that subject, according to the Absolute Novelty Bar.” 
Depending on the country, there may be limited 
exceptions, serving only to further complicate the 
matter and making the expertise of someone like 
Jay Pattumudi all the more valuable. 
Always learning 
A science or engineering background is a 
requirement for all patent attorneys and a keen 
interest in technology is important too, says 
Pattumudi, who considers himself a perpetual 
learner. While some patent attorneys are solely 
focused in one area, such as biotechnology or 
pharmaceuticals, Pattumudi has worked in many 
technical fields and most areas of patent law except 
litigation. Having a B.S. in biological sciences from 
Fordham University, in addition to his master’s from 
New York Medical College, has boosted his ability 
to assimilate different research concepts. His fluency 
in these areas allows him to assist clients in taking 
their ideas from experimentation to real-world use. 
“I keep up on certain things that I was interested 
in while I was in graduate school, such as 
adenoviral vectors in gene therapy,” Pattumudi 
says. “It’s interesting to me to see how that field 
is progressing, and I can do that by keeping up 
with whatever my clients are working on”—which 
could be anything from biotechnology to aircraft 
cabin technology. “I’m often required to learn what 
An interest in science and legal rights led this former 
basic scientist from the laboratory to the legal field, 
where patent law and researchers struggle to coexist.
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Milestones
’06 and ’07
Angel M. Garcia Otano, 
M.D. ’06, and Dana M. 
Delach, M.D. ’07, are mar-
ried. Both are second-year 
residents at the Williamsport 
Hospital Family Medicine 
Residency Program in  
Williamsport, Pa. 
’03
Cathie T. Jones, M.D. ’03, 
completed a fellowship in 
pediatric anesthesiology at 
Children’s Hospital in Boston. 
Dr. Jones is now on staff at 
Wilford Hall Medical Center 
with the U.S. Air Force in San 
Antonio, Tex., where she lives 
with her husband Jared and 
daughter Lillian.
’02
Roger R. Feo, M.D. ’02, 
who graduated from the 
Fifth Pathway Program at St. 
Vincent’s Medical Center in 
Bridgeport, Conn., completed 
his general hospital family 
medicine residency in 2008. Dr. 
Feo practices at Berks Family 
Care-Pottstown Memorial 
Medical in Douglassville, Pa.
’01
Timothy McClung, M.S., 
M.P.H., ’01, is director of 
quality improvement op-
erations at Norwalk Hospital 
(Conn.)  He is a fellow of the 
American College of Health-
care Executives.
’00
Susan L. Morton-Pradham, 
M.D. ’00, was inducted into 
the Cambridge Who’s Who 
Executive, Professional and 
Entrepreneurial Registry. Dr. 
Morton-Pradham is a physician 
for Chloe Obstetrics and 
Gynecology in Phoenix, Ariz.
the90s
Keith Berkowitz, M.D. ’95, 
has co-authored The Stubborn 
Fat Fix—Eat Right to Lose Weight 
and Cure Metabolic Burnout 
without Hunger or Exercise. Dr. 
Goldstein is founder and medi-
cal director of the Center for 
Balanced Health in New York 
City and a former medical 
director of the Atkins Center 
for Complementary Medicine. 
Andrew O. Chow, M.D. ’95, 
is on the staff of Health First 
in Fairfield, Conn., a facil-
ity “specializing in restoring, 
maintaining and optimizing 
the health of the Boomer 
Generation.” Dr. Chow is a 
Stanford-trained acupuncturist 
and an active member of the 
American Academy of Medical 
Acupuncture.
Catherine G. Winkler, 
M.P.H. ’95, has received her 
doctorate from Yale and is a 
nurse at Danbury Hospital 
(Conn.), specializing in  
cardiovascular disease.
Tess Kryspin, M.D. ’94, is a 
certified physician executive 
and director of ambulatory 
practice for the Griffin Faculty 
David Goldenberg, M.D. ’82
Remember shop? As in woodshop, where students made tie racks and coat hooks? For some, it was a high school elective, respite from the drudge of academics. For others like David Goldenberg, M.D. ’82, shop is a place 
for solving problems, for learning focus and self-discipline—distant values in this 
instant-gratification, multi-tasking age of cell-phones, Twitter and Facebook. “People 
are enormously distracted, and kids today are horribly unfocused,” Dr. Goldenberg 
says. What’s more, he adds, “People have forgotten how to make things.”
Dr. Goldenberg, a Connecticut-based plastic surgeon, has spent his life making 
things. When he is not seeing patients in his Danbury office or making rounds as 
chief of plastic surgery at Danbury Hospital, he is in his shop, casting a concrete 
tabletop for plants, crafting knives or jewelry, building a telescope or making  
surgical instruments. “I make anything, I don’t care what it is…every spare  
minute,” he says. “The hobby is making.”
Teaching a skill
Mastering a craft,
By Andrea Kott, M.P.H.
School of  
Public Health  
Changes 
Its Name
On June 1 the School of Public Health officially became the School of Health Sciences and Practice, and established the 
Institute of Public Health. The school’s new name, leaders say, reflects a restructuring of the school’s mission, as well as a new 
organizational scheme that offers more flexibility in planning degree programs and academic offerings. The School of Health 
Sciences and Practice will comprise three accredited professional programs—in public health, speech-language pathology, 
and physical therapy. The public health program will consist of three departments: Environmental Health Science, Epidemiol-
ogy and Community Health, and Health Policy and Management. In addition, the new Institute of Public Health will expand 
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Practice Plan in Oxford, Conn. 
Dr. Kryspin is board certified 
in medical management.
Janet A. Stockheim, M.D. 
’91, M.P.H. ’92, a clinical as-
sistant professor of pediatrics 
at NYMC, has written Nothing 
but Newborn:  A First-month 
Primer for Parents, a book for 
new mothers. Dr. Stockheim 
lives with her family in Pleas-
antville, N.Y.
Roger A. Gallup, M.D. ’91, 
is a Colonel in the U.S. Army 
and a III Corps Surgeon at Ft. 
Hood, Tex., where he special-
izes in pulmonary/critical care.
Mark J. Sterling, M.D. ’91, 
who specializes in physical 
medicine and rehabilitation, is 
acting chairman in the division 
of physical medicine and re-
habilitation at St. Catherine of 
Siena Hospital, Smithtown, N.Y.
Michael J. Traurig, M.D. ’91, 
is a board certified phlebolo-
gist. Dr. Traurig treats diseases 
of the veins. He lives in Green-
ville, S.C., with wife Nancy and 
their two children, Julianna, 12, 
and Alaynah, 10.
the80s
Alan H. Cohen, M.D. ’88, 
works at MAP Pharmaceuticals 
in Mountain View, Calif., where 
he is Vice President of Clinical 
Development and Medical 
Affairs, Pulmonary.
Michael Fredericson, M.D. 
’88, is professor of orthopedic 
surgery at Stanford University 
in Palo Alto, Calif. Dr. Freder-
icson’s research focuses on 
the etiology, prevention and 
treatment of overuse injuries; 
patellofemoral pain, and stress 
Teaching a skill
By Andrea Kott, M.P.H.
Long before he became a physician, Dr. Goldenberg was a machinist. 
He ran metalworking equipment in high school and worked summers 
in machine shops. He always planned to attend medical school and 
knew plastic surgery was the specialty that suited him best. “I’m an 
anatomic problem solver,” he says. “The satisfaction in plastic surgery 
is being able to solve problems, getting a wound to close, repairing a 
breast, restoring facial symmetry.”
While he finds medicine much more challenging than, say, fashioning an 
arrowhead, he loves both because he appreciates shape and creativity. 
“They go together very well,” he says.  “Plastic surgery is really just 
moving the tissues around, and what I do in the shop—knife making, 
stone carving, building telescopes, blacksmithing—works from the same 
concept of taking raw materials and shaping them into tools, devices 
and machines.” 
One of Dr. Goldenberg’s favorite projects is building telescopes. “I’m 
always building the next biggest telescope,” he says. It isn’t the result 
alone that Goldenberg prizes, however.  It is the process and the 
commitment and concentration it requires, qualities he says are not 
promoted in today’s education system. This is why he insisted that each 
of his three children, two of whom are now grown, build a telescope 
for the science fair during high school. (His 16-year-old son recently 
won first place in his school fair’s senior division.)
“You’ve got make kids focus,” Dr. Goldenberg says. “They’re so used to 
multi-tasking that they can’t focus on a task and finish it.” He gave his 
kids no choice. He told them, “God help you if you’re upstairs playing 
a video game while I’m downstairs learning something. You’re going 
to learn to use a table saw. You’re going to figure this out. There’s no 
instant messaging, no talking to friends, no cell phones, no interruptions. 
You do it until it’s done right.” And they did. “The first time you look at 
a magnified vision of the moon through your own telescope…you’ve 
got to see the smiles on their faces.”
Dr. Goldenberg is trying to cultivate self-reliance, not self-satisfaction. 
“My wife tells my son to take the triple-A card with him in case he gets 
a flat, and I say, ‘Teach him how to change a tire!’” he exclaims. “Society 
makes it easy to be dependent on others. Whatever happened to  
self-reliance and confidence in your own abilities?”
Even when things go wrong, there is plenty to learn from process and 
outcomes, he says. “You can’t be afraid of failure. Too many people 
don’t do woodworking or a craft because they can’t get past the initial 
hump of failure. I fail all the time. I’m always making mistakes, but that’s 
how I get better.”
At 53, Dr. Goldenberg is thinking about retirement. For years, he has 
been writing a book about the history of surgical instruments. He also 
has been planning to build a bigger, freestanding shop where he might 
start building things to sell.  “It doesn’t sit right with me that I have a 
hobby that consumes but doesn’t produce any income,” he says, noting 
the economic downturn. So he is considering selling hand-carved stone 
planters for bonsai trees—unless he decides to dedicate himself to 
making knives. Whatever he chooses, perhaps his “shop motto” will be 
the phrase that he once used with his children:  “Come with me, sit  
by my side. I’ll teach you something that you can use for the rest of 
your life.”p
Jay S. Pattumudi, J.D., M.S. ’98
(continued from page 26)
makes an invention unique,” Pattumudi says. “Just keeping 
up with the law is challenging enough, but patent attorneys 
have clients in many technological fields. I think I’m more 
enriched by working in so many different areas.”
Late last year, Pattumudi and his wife Vaishnavi relocated 
from Florida to New Jersey, where they have family nearby. 
It’s also where he now works for Hoxie and Associates, LLC, 
a firm that specializes in patents for biotechnology, medical 
devices and pharmaceuticals. Though he is specialized in 
one area of law, as a patent lawyer he considers himself a 
generalist when it comes to technology.
He enjoys answering people’s questions about patents, even 
if the answers are not always what the person wants to hear. 
“When someone asks me to research an invention that they 
think is patentable and it quickly becomes obvious that isn’t, 
I tell them so. Sometimes it leads them to a different line 
of thinking and they end up making a better product—you 
know, the proverbial ‘better mousetrap.’ In the end, that 
might be good for lots of people, and professionally, that’s 
very fulfilling for me.”p
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fractures in athletes. In addi-
tion to serving as chief of the 
physical medicine and reha-
bilitation outpatient clinics at 
Stanford Hospital and Clinics, 
he is team physician for Stan-
ford sports teams and senior 
associate editor of PM&R, the 
journal of injury, function and 
rehabilitation. 
John Panella, Jr., M.A., 
M.P.H. ’88, is executive direc-
tor of the Baltimore office of 
SeniorBridge, an organization 
that serves seniors and their 
families by managing chronic 
health care needs in the home 
and other settings.
Joseph R. Wax, M.D. ’86, 
returned to the Valhalla area 
for the Seventh Annual Hud-
son Valley Regional Perinatal 
Forum in November 2008, 
where he presented the latest 
in female reproductive issues 
following bariatric surgery.  
Dr. Wax, professor of obstet-
rics and gynecology at the 
University of Vermont School 
of Medicine, Maine Medical 
Center in Portland, special-
izes in high-risk obstetrics and 
ultrasound. 
David R. Charnock, M.D. 
’84, practices otolaryngol-
ogy at Mid-Vermont ENT in 
Rutland. Dr. Charnock reports 
that his oldest son graduates 
college the same weekend 
as his 25th NYMC reunion. 
“Three more to go!”
Kevin C. Delahanty, 
M.D. ’84, practices internal 
medicine with a small group 
in Salisbury, Mass. In 2006, 
Dr. Delahanty retired after 
26 years in the U.S. Navy and 
relocated from Seattle, Wa., to 
his current home in Newbury-
port, Mass. He married Joan 
Elizabeth in 2001 and is the 
father of two.
Andre Konski, M.D. ’84, 
M.B.A., is chair of the depart-
ment of radiation oncology 
for the Wayne State University 
School of Medicine and service 
chief for radiation oncology 
at the Barbara Ann Karmanos 
Cancer Center in Detroit, Mich.
Miriam David, M.D. ’83, 
married Richard B. Stranger on 
March 29, 2009. She is director 
of breast magnetic resonance 
imaging in the department of 
radiology at Jacobi Medical 
Center in the Bronx. 
Jill S. Hirsch, M.D. ’80, 
reports that twin daughters 
Allison and Jessica are in 
their third year of a Ph.D 
program in organic chemistry 
at the University of California, 
Berkeley. Youngest daughter 
Larissa is a Drew Univer-
sity senior, also majoring in 
organic chemistry. Dr. Hirsch’s 
husband, Randolph Cohen, 
M.D. ’80, is working in a large 
multispecialty group in Middle-
town, N.Y.
the70s
Edward Scott Valentine, 
M.D. ’78, is currently a 
student in the Yale M.B.A. 
for Executives: Leadership in 
Healthcare program, Class 
of 2010.
In work, as in life, it is the detours that have brought this alumnus home. And home happens to be in Franktown, Virginia—not exactly where Stuart Mackler, M.D. ’63, imagined he’d settle when he became an orthopedic 
surgeon more than 40 years ago and headed to Boston for an internship and 
residency at Beth Israel Hospital. 
“It’s all because of New York Medical College,” Dr. Mackler says with unabashed 
appreciation. It was there, as the fourth-year student president of the Phi Chi 
medical fraternity, that he attended a lecture where Charles Bailey, M.D., spoke 
about achieving satisfaction in medicine—professional, not monetary, satisfac-
tion. Bailey was the world famous cardiovascular surgeon and then-chairman of 
Beth Israel’s department of surgery.
“He recommended practicing in a rural area, because doctors were needed 
there,” says Dr. Mackler, who retired in 2004. So, when he noticed an ad in a 
medical journal for an orthopedic surgeon in Virginia, he applied. “Within six 
months I was in Radford, a town of 15,000,” he says. “I was the first and only 
orthopedic surgeon between Roanoke and Abingdon, Virginia.” 
It was 1976, and at the time there weren’t enough orthopedic surgeons to 
populate the country. “I did get that satisfaction from being needed,” Dr.  
Mackler says. “I got so busy I couldn’t take a vacation.”
It wasn’t just his professional practice that made Dr. Mackler feel content. It 
was also living where he did. “There’s something about a smaller community,” 
he says. “People know you by name when they run into you on the street. You 
don’t get that in a big city.” 
Dr. Mackler speaks modestly about his career achievements, but his CV reveals 
another side of his life. He is currently a captain in the U.S. Public Health  
Service Reserve, having served as a senior medical officer in Coast Guard  Stuart Mackler, M.D. ’63
from the 
Inside and Out
Looking at Medicine 
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Dennis Roggemann, M.D. 
‘76, is a cardiologist in Fort 
Lauderdale, Fla., who devotes 
his practice exclusively to 
interpreting echocardiograms 
via the internet. “My current 
endeavor is to enable the 
ultrasound of the heart to be 
performed wherever a physi-
cian encounters a patient.”  
Richard Kresch, M.D. ’71, 
is president and chief execu-
tive officer of Ascend Health 
Corp., which is renovating 
and converting the old Cedar 
Hills Hospital in Portland, 
Ore., into a 36-bed psychiat-
ric facility.
Ian Gale, M.D. ’70, is “still 
practicing in Los Angeles, 
after 32 years as a urologist.” 
Dr. Gale and wife Lisa, a 
flight attendant for American 
Airlines, travel the world 
extensively when they’re  
not visiting their four grand-
children.
the60s
Robert J. Master, M.D. ’68,  
received an award in March 
2009 from the National 
Committee for Quality As-
surance for his leadership 
in improving the quality of 
care for vulnerable popula-
tions, especially the frail and 
disabled.
Edwin S. Stempler, M.D. 
’61, is practicing orthopedics 
(with a strong osteoporosis 
program) part time in  
Rancho Mirage, Calif.
Squadron 3 in Vietnam from 1967-1968. He was awarded the Republic of 
Vietnam Campaign Medal, Vietnam Service Medal, National Defense Service 
Medal, the Sikorsky Air Rescue Award, as well as the 1990 Certificate of  
Appreciation from the U.S. Department of Health and Human Services.
Dr. Mackler is equally reserved when he talks about Virginia Governor 
Timothy Kaine appointing him in 2008 to the Virginia Board of Medicine, an 
unexpected and very timely honor. “It’s difficult for someone to just go cold 
turkey and stop practicing medicine,” he says, “so it’s nice to keep your hand 
in the field.”
Sitting on the board is a volunteer post to which Dr. Mackler devotes 15 to 
20 days each month, regularly driving nearly three hours to Richmond for 
hearings and reviewing approximately 12 cases. “It is a very interesting job,” 
he says, describing the board’s oversight of physicians, osteopaths, interns, 
residents, athletic trainers, physician assistants, acupuncturists, radiology 
technicians and respiratory care practitioners. “We have more than 30,000 
licenses,” he says. 
It is eye-opening for any physician to be in the position of policing his peers, 
especially in a climate that has grown increasingly litigious. “I’ve become aware 
of how the system of law and the system of medicine are so intertwined,” Dr. 
Mackler says.  
He finds that, on balance, very few physicians come before boards for infrac-
tions. “There is the colleague who generally gives excellent care and makes 
the occasional error of judgment—an omission, a missed diagnosis, a choice 
made that doesn’t serve the patient well. It can happen to anyone, even the 
best doctors in the country,” he says. “Perfection is not a part of medicine any 
more than it is part of any other endeavor.” Yet, he says, “It’s a very important 
thing that we police ourselves.”p
Dawn P. Dawson, M.D. ’91, 
died August 20, 2008. She was 45.
John B. Montana, M.D. ’79, 
died September 28, 2008. He 
was 61.
Richard L. Brown, M.D. ’75, 
died November 28, 2008. He 
was 59.
R. Harold Parmalee, M.D. ’73, 
died December 19, 2008.
James P. Angiulo, M.D. ’72, 
J.D., died February 8, 2009. He 
was 61. 
Kwabena A. Addei, M.D. ’68, 
died November 8, 2008. 
Melvin Gerber, M.D. ’64, died 
April 7, 2008.
Arthur L. McGovern, M.D. 
’62, died November 14, 2008. He 
was 71.
Harry C. Smith, M.D. ’61, died 
December 17, 2008. He was 74.
Daniel M. Baer, M.D. ’57, died 
April 5, 2009.
Benjamin Lamstein, M.D. ’57, 
died October 29, 2007.
Thomas P. Mathews, M.D. 
’57, died November 19, 2008. He 
was 77.
Lawrence A. Norton, M.D. ’56, 
died May 13, 2009. He was 78.
Robert Dickinson, M.D. ’55, 
died February 18, 2008. 
John A. Schultz, M.D. ’55, died 
March 25, 2009. 
William R. Flynn, M.D. ’54, 
died April 15, 2009. 
Glenn S. Aggerup, M.D. ’53, 
died March 10, 2009. He was 80.
Vernon E. Thomas, M.D. ’52, 
died February 26, 2008.
Walter G. Elliot, M.D. ’51, died 
September 12, 2008. He was 90.
Theodore S. Smith, M.D. ’51, 
died October 29, 2008.
Albert M. Ondrako, M.D. ’49, 
died June 16, 2008.
Nicholas Antoszyk, M.D. 
’48, died November 3, 2008. He 
was 87.
Arthur S. Kaplan, M.D. ’48, 
died April 14, 2009.
Philip R. Gale, M.D. ’46, died 
December 12, 2008.
Elisabeth M.F. Shanks, M.D. 
’46, died July 3, 2008.
Anthony Barbaccia, M.D. ’45, 
died June 14, 2008.
Julian F. DuBois, Jr., M.D. ’45, 
died December 16, 2007. He 
was 90.
Martin Nissel, M.D. ’44, died 
January 28, 2009.
Robert Northway-Meyer, 
M.D. ’44, died December 27, 
2007.
Joseph F. Maiorano, M.D. ’43, 
died July 23, 2008. He was 89.
Wallace T. McCaffrey, M.D. 
’43, died October 29, 2008.
Jeanne S. Miller, M.D. ’43, died 
January 3, 2009.
Norman D. Stevens, M.D. 
’43, died November 1, 2008. He 
was 89.
David I. Kraft, M.D. ’42, died 
October 29, 2008.
Robert C. Burnham, M.D. ’41, 
died April 20, 2008.
Irving S. Behr, M.D. ’39, died 
September 11, 2007.
Thomas G. Caceci, M.D. ’39, 
died January 2, 2009. He was 94.
S. T. Coppola, M.D. ’39, died 
June 27, 2008.
Charles J. Grubin, M.D. ’39, 
died January 26, 2009.
Nathan Arenson, M.D. ’37, 
died April 2, 2008.
Morris D. Rudick, M.D. ’32, 
died December 4, 2008. He  
was 99.
Faculty
Sheila Dotson Davis, M.D., 
professor of clinical radiology at 
Westchester Medical Center, died 
May 11, 2009.
Paul L. Chodosh, M.D., clinical 
professor of otolaryngology at The 
New York Eye and Ear Infirmary, 
died September 6, 2008. He  
was 84.
Mark H. Friedman, D.D.S., 
clinical associate professor of 
dental medicine, of medicine, and 
of cell biology and anatomy at 
Westchester Medical Center, died 
December 18, 2008.
In Memoriam 
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physical and mental health are likely to worsen over time 
and not necessarily expect that they will “bounce back,” 
although declines in physical health are likely to be greater 
than declines in mental health. 
“Changes in Health-Related Quality of Life of Newly Diagnosed Cancer 
Patients, Cancer Survivors and Controls,” Cancer, April 28, 2009.
 Is there an alternative theory of evolution?
The animal kingdom, or Metazoa, arose from single-celled 
ancestors in a few bursts of several million years between 
500 and 600 million years ago. Embryos of all animal 
groups—those containing insects, oysters, worms and 
vertebrates like ourselves—use the same set of proteins 
to produce their complex forms. According to Darwin’s 
theory of natural selection, the major evolutionary steps 
needed to generate animal forms would have required 
much more genetic change and happened slowly. 
Now a growing number of developmental biologists are 
trying to understand how the transition from single-cell to 
complex animal forms happened so abruptly. Stuart A. 
Newman, Ph.D., professor of cell biology and anatomy, 
has presented a new mechanism to explain these early 
evolutionary steps, one that recognizes the role of the 
material properties of cell aggregates in the generation  
of biological form and pattern. Eons ago, changes in the 
environment caused some ancient proteins already present 
on the surfaces of single cells to clump the cells into multi-
cellular clusters. Once these clusters existed, the products 
of other previously existing genes began to mobilize physical 
mechanisms and effects not relevant on the smaller spatial 
scale of the individual cell to mediate the formation of 
hollow, multilayered, segmented, appendage-bearing forms.
The result was a “pattern language” capable of generating 
all body plans and organ forms of the animals.
“Dynamical patterning modules: a ‘pattern language’ for development and 
evolution of multicellular form,”  The International Journal of Developmental 
Biology, in press, online at http://www.ijdb.ehu.es/web/paper.php?doi=10.1387/
ijdb.072481sn
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Photos by John Vecchiolla, except 1, 2 (courtesy of Department of Medicine), 18, 20 (Photobureau), and 19 (Lisa Wanderman).
  1.  At the Alpha Omega Alpha (AOA) induction cer-
emony on March 25, alumni initiate Peter A. Indelicato, 
M.D. ’69, was congratulated by AOA chapter councilor 
William H. Frishman, M.D., and Edmund F. LaGamma, 
M.D. ’76.
  2.  AOA alumni initiate James E. Udelson, M.D. ’81, was 
joined by AOA president Julie Krystal, Class of 2009, 
and AOA junior member Allyson Chesebro, Class of 
2010.  
 3.  Laurence Friedman, M.D. ’59, and his wife Marilyn 
Friedman attended his 50th reunion at the New York 
Sheraton on May 16.
  4. James Voskovitch, M.D. ’59, and Diane Bauer.
  5. Members of the Class of 1959.
  6. John Weg, M.D. ’59, and Mary Loretta Weg.
  7.  Congratulating Mark Rosenblum, M.D. 69, winner of 
an Alumni Medal of Honor, were Ralph A. O’Connell, 
M.D., provost and dean; Eileen M. Dieck, ’86, Alumni 
Association President; and Karl P. Adler, M.D., College 
president and CEO.
  8.  Class of 2009’s Jeffrey Eliason was selected to give 
the student address at Commencement, while Angela 
Fusaro, Student Senate president, received the Alumni 
Endowed Scholarship.
  9. Members of the Class of 1984.
10.  Angela Fusaro, Class of ’09, was presented with the 
Alumni Endowed Scholarship by Eileen M. Dieck, ’86, 
Alumni Association President, and Karl P. Adler, M.D., 
NYMC President and CEO.
11.  Medal of Honor winner Mark Rosenblum, M.D. ’69, 
and his wife Pam Rosenblum.
12.  Joseph Dursi, M.D. ’59, associate dean for continuing 
medical education, and Benjamin Sadock, M.D. ’59.
13.  Michael Grenis, M.D. ’84, Medal of Honor recipient  
Joseph Cervia M.D. ’84, and Mario Tagliabambe, M.D. 
’84.
14.  Herman Schaffer, M.D. ’59, Bernard Sonnenblick, M.D. 
’59, and Lawrence Sheff, M.D. ’59. 
15.  Honoree Joseph Cervia, M.D. ’84, was joined by De-
nise Blumberg, M.D., Carol Swift, and Steven Carolan, 
M.D. ’84.
16.  Friends and spouses of the Class of 1984 were ready 
with their cameras when the celebrants assembled 
for a portrait. 
17. Tedd Weisman, M.D. ’84, and Michael Grenis, M.D. ’84.
18.  A very proud Peter Coffin, M.D. ’75, posed with son 
Samuel Coffin, M.D. ’09, at Commencement in May.
19.  At age 98 the oldest alumnus to attend the May 
17 reunion luncheon, Sidney Wanderman, M.D. ’34, 
stood before a portrait of Dr. Walter Gray Crump, his 
former professor of surgery.
20.  Lawrence Sahler, M.D. ’88, and son Christopher Sahler, 
M.D. ’09, at Commencement.
10. 9. 
12. 11. 13. 
15. 
16. 
17. 18. 19. 20. 
14. 
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